Strata Critical Medical (BLDE) officer has 21,643 shares withheld for taxes

Rhea-AI Filing Summary

Strata Critical Medical, Inc. reported an insider transaction by an officer who serves as CEO of Trinity Air Medical. On 12/10/2025, the officer had 21,643 shares of Class A common stock withheld at $4.38 per share, recorded under transaction code F, in connection with tax withholding on vesting restricted stock units.

After this transaction, the officer beneficially owned 293,395 shares directly and 382,987 shares indirectly through a limited liability company of which the officer is the sole member. The filing describes the transaction as issuer share withholding to satisfy tax obligations related to equity compensation.

Insider Trade Summary

Net Seller: 21,643 shares

Net Sell 2 txns

Insider Wunsch Scott M

Role CEO, Trinity Air Medical

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Class A common stock, $0.0001 par value per share	21,643	$4.38	$95K
holding	Class A common stock, $0.0001 par value per share	--	--	--

Holdings After Transaction: Class A common stock, $0.0001 par value per share — 293,395 shares (Direct); Class A common stock, $0.0001 par value per share — 382,987 shares (Indirect, See Footnotes)

Footnotes (2)

1. F1. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
2. F2. Held directly by a limited liability company of which the Reporting Person is the sole member.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/12/2025 - 04:06 PM Learn about SEC filing dates

FAQ

What insider transaction did Strata Critical Medical (BLDE) report in this filing?

The filing reports that an officer of Strata Critical Medical, Inc., who is CEO of Trinity Air Medical, had 21,643 shares of Class A common stock withheld on 12/10/2025 to cover tax obligations from vesting restricted stock units.

At what price were Strata Critical Medical (BLDE) shares withheld for taxes?

The issuer withheld 21,643 shares of Class A common stock at a price of $4.38 per share to satisfy tax withholding obligations tied to restricted stock unit vesting.

How many Strata Critical Medical (BLDE) shares does the insider own after this transaction?

Following the reported transaction, the officer beneficially owned 293,395 shares of Class A common stock directly and 382,987 shares indirectly through a limited liability company.

What is the relationship of the reporting person to Strata Critical Medical (BLDE)?

The reporting person is an officer of Strata Critical Medical, Inc., with the title CEO, Trinity Air Medical, as indicated in the filing.

How are the indirectly owned Strata Critical Medical (BLDE) shares held?

The filing states that the 382,987 indirectly owned shares are held by a limited liability company of which the reporting person is the sole member.

What does transaction code F mean in this Strata Critical Medical (BLDE) insider filing?

Transaction code F is used here for shares that were withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wunsch Scott M

(Last) (First) (Middle)

C/O STRATA CRITICAL MEDICAL, INC.

31 HUDSON YARDS, 14TH FLOOR

(Street)

NEW YORK NY 10001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, Trinity Air Medical

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock, $0.0001 par value per share	12/10/2025		F(1)		21,643	D	$4.38	293,395	D
Class A common stock, $0.0001 par value per share								382,987	I(2)	See Footnotes

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

2. Held directly by a limited liability company of which the Reporting Person is the sole member.

Remarks:

	/s/ Melissa M. Tomkiel, Attorney-in-fact for Scott M. Wunsch	12/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.